Cargando…

Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472126/ https://www.ncbi.nlm.nih.gov/pubmed/36096540 http://dx.doi.org/10.1136/jitc-2021-003960corr1

Ejemplares similares

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
por: Jiang, Xiaoyi, et al.
Publicado: (2022)

A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017)

Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023)

STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy
por: Zhou, Lei, et al.
Publicado: (2023)

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
por: Su, Ting, et al.
Publicado: (2022)

A Magnetic Nanovaccine Enhances Cancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2019)

Correction to T‐cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy
Publicado: (2023)

STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
por: Zhang, Bo-Dou, et al.
Publicado: (2022)

In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)

Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
por: Fang, Xingliang, et al.
Publicado: (2022)

Artificially cloaked viral nanovaccine for cancer immunotherapy
por: Fusciello, Manlio, et al.
Publicado: (2019)

CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen, Wenqiang, et al.
Publicado: (2021)

Research progress of nanovaccine in anti-tumor immunotherapy
por: Yao, Min, et al.
Publicado: (2023)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018)

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021)

Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy
por: Zhao, Peiqi, et al.
Publicado: (2022)

Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
por: Cai, Ting, et al.
Publicado: (2021)

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
por: Shi, Yaoyao, et al.
Publicado: (2020)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023)

Correction to: Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
por: Zhang, Chuan-xia, et al.
Publicado: (2022)

Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
por: Dong, Ying, et al.
Publicado: (2020)

Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014)

Correction: Silica Vesicle Nanovaccine Formulations Stimulate Long-Term Immune Responses to the Bovine Viral Diarrhoea Virus E2 Protein
por: Mody, Karishma T., et al.
Publicado: (2016)

STING activation in cancer immunotherapy
por: Su, Ting, et al.
Publicado: (2019)

Correction: Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents
por: Gaston, Julie, et al.
Publicado: (2019)

Correction: Extracellular vesicles package dsDNA to aggravate Crohn’s disease by activating the STING pathway
por: Zhao, Fan, et al.
Publicado: (2021)

Effects of Combinatorial Ubiquitinated Protein-Based Nanovaccine and STING Agonist in Mice With Drug-Resistant and Metastatic Breast Cancer
por: Huang, Fang, et al.
Publicado: (2021)

Correction to: The transmittable through stinging microbiota differs between honeybees and wasps: a potentially greater microbial risk of the wasp sting for humans
por: Gkitsaki, Ioanna, et al.
Publicado: (2023)

Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2022)

Correction: Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
Publicado: (2020)

Correction: Diagnostic Biopsy Does Not Commonly Induce Intratumoral CD8 T Cell Infiltration in Merkel Cell Carcinoma
por: Koba, Shinichi, et al.
Publicado: (2012)

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
por: Zaidi, Ali H., et al.
Publicado: (2021)

Correction: Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
por: Zito Marino, Federica, et al.
Publicado: (2015)

Correction: From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2016)

Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2019)

Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy
por: Jiang, Mingxia, et al.
Publicado: (2021)

Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
por: He, Ao, et al.
Publicado: (2023)

Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma
por: Boudreau, C. Elizabeth, et al.
Publicado: (2021)

Author Correction: Prolonged activation of innate immune pathways by a polyvalent STING agonist
por: Li, Suxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tnabsaq989stebakq4nh022kon